|
Alzheimer's disease
Citations 1-10 of 570 total displayed.
|
Most recent content
(18 Nov 2009):
|
- ARTICLES
A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- S. Salloway, R. Sperling, S. Gilman, N. C. Fox, K. Blennow, M. Raskind, M. Sabbagh, L. S. Honig, R. Doody, C. H. van Dyck, R. Mulnard, J. Barakos, K. M. Gregg, E. Liu, I. Lieberburg, D. Schenk, R. Black, Michael Grundman For the Bapineuzumab 201 Clinical Trial Investigators
Neurology first published on November 18, 2009 as doi: WNL.0b013e3181c67808.
[Abstract]
Rapid PDF
|
Past content
(since Jan 2001):
|
- ARTICLES
Cortical event-related potentials in preclinical familial Alzheimer disease
- E. J. Golob, J. M. Ringman, R. Irimajiri, S. Bright, B. Schaffer, L. D. Medina, and A. Starr
Neurology 2009; 73: 1649-1655.
[Abstract]
[Full text]
[PDF]
- ARTICLES
CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease
- D. B. Clifford, A. M. Fagan, D. M. Holtzman, J. C. Morris, M. Teshome, A. R. Shah, and J. S. K. Kauwe
Neurology first published on November 11, 2009 as doi: WNL.0b013e3181c5b445.
[Abstract]
Rapid PDF
- ARTICLES
Adiposity indicators and dementia over 32 years in Sweden
- D. R. Gustafson, K. Bäckman, M. Waern, S. Östling, X. Guo, P. Zandi, M. M. Mielke, C. Bengtsson, and I. Skoog
Neurology 2009; 73: 1559-1566.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Clinical syndromes associated with posterior atrophy: Early age at onset AD spectrum
- R. Migliaccio, F. Agosta, K. Rascovsky, A. Karydas, S. Bonasera, G. D. Rabinovici, B. L. Miller, and M. L. Gorno-Tempini
Neurology 2009; 73: 1571-1578.
[Abstract]
[Full text]
[PDF]
- EDITORIALS
Predicting conversion to mild cognitive impairment: Some error is the price of much truth
- Merrill F. Elias and Adam Davey
Neurology 2009; 73: 1432-1433.
[Full text]
[PDF]
- ARTICLES
Predicting the time of conversion to MCI in the elderly: Role of verbal expression and learning
- Abderrahim Oulhaj, Gordon K. Wilcock, A. David Smith, and Celeste A. de Jager
Neurology 2009; 73: 1436-1442.
[Abstract]
[Full text]
[PDF]
- ARTICLES
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
- M. I. Kester, A. E. van der Vlies, M. A. Blankenstein, Y.A.L. Pijnenburg, E. J. van Elk, P. Scheltens, and W. M. van der Flier
Neurology 2009; 73: 1353-1358.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease
- C. Sanz, S. Andrieu, A. Sinclair, H. Hanaire, B. Vellas For the REAL.FR Study Group
Neurology 2009; 73: 1359-1366.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Age, Alzheimer disease, and brain structure
- C. A. Raji, O. L. Lopez, L. H. Kuller, O. T. Carmichael, and J. T. Becker
Neurology first published on October 21, 2009 as doi: WNL.0b013e3181c3f293.
[Abstract]
Rapid PDF
|
|
